Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds
Research published in the NEJM suggests two doses of Pfizer/BioNTech or AstraZeneca's COVID-19 vaccines are nearly as effective against the highly transmissible Delta variant as they are against t...
AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases
AstraZeneca’s mega $39 billion takeover of Alexion Pharmaceuticals has come to a close, delivering the British pharma a lucrative portfolio of immunology medicines and a towering presence in rare di...
AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront
AstraZeneca (AZ) has entered an exclusive license agreement with Aridis Pharmaceuticals for its late-stage monoclonal antibody (mAb) candidate suvratoxumab.
Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility to Increase Biologics Manufacturing Capabilities in Europe
SOMERSET, N.
First Total Artificial Heart Successfully Transplanted In the US
The artificial heart has four chambers and runs on external power.
FDA Approves Tacrolimus for Lung Transplants in Adults, Kids. The first immunosuppressant approved for this population
The FDA has approved tacrolimus in combination with other immunosuppressants for the prevention of organ rejection in adults and kids receiving lung transplantation.
FDA Approves Sleeping Sickness Therapy
The federal agency gives nod for fexinidazole as the first all-oral treatment for the parasitic illness.
U.S. states to unveil $26 billion opioid settlement with drug distributors, J&J - sources
(Reuters) - U.
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
MAINZ, Germany & Santa Monica, USA, July 19, 2021 – BioNTech SE (Nasdaq.
BioNTech Produces 10 Times More Antibodies than China's Sinovac: Study
People who received BioNTech's coronavirus vaccine had ten times the amount of antibodies than those given China's Sinovac, a Hong Kong study has shown, adding to growing data on different jab...
Kadmon shares jump on FDA approval of Rezurock for chronic GvHD
Shares in Kadmon Pharmaceuticals were up more than 20% on Friday after the FDA approved its oral kinase inhibitor Rezurock (belumosudil) for chronic graft-versus-host disease (GvHD)...
VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Caused by 15 Serotypes
KENILWORTH, N.
245
246
247
248
249
250
251
252
253
